Fueling the future of precision medicine and targeted therapies with NGS-based companion diagnostics (Dx).
Illumina provides an innovative portfolio of NGS systems, products, and services for many phases of the drug development pipeline.
This DrugDev Consortium-designed genotyping array covers ADME genes and the druggable genome to support drug target selection and validation.